Credit Suisse Rehires Health-Care Investment Banker Nikhil Goel
(Bloomberg) -- Credit Suisse Group AG rehired health-care mergers and acquisitions banker Nikhil Goel, according to people with knowledge of the matter.
Goel, who is based in New York, is set to rejoin the Swiss lender as a managing director, reporting to global co-head of M&A Steve Geller, the people said, asking not to be identified because the hiring isn't yet public.
Goel resigned last year to join Absci Corp. as chief strategy officer after more than five years at Credit Suisse, where he was last a director. His move back to the bank comes amid both an effort by management to replenish senior ranks after a slew of defections and a comprehensive strategic review. Over the past year, the bank has hired Joel Thompson, Scott Bardo, Eric Francois, Peter Kerrane and Mark Filenbaum as managing directors focused on health-care dealmaking.
Shares of the Zurich-based firm, which this week said its global head of credit products and co-head of global banking are leaving, hit a record low on Thursday.
A Credit Suisse spokeswoman declined to comment. Absci and Goel agreed his “employment with the company would end effective as of Sept. 20,” Absci said in a regulatory filing this month. Goel didn't immediately respond to a request for comment.
More stories like this are available on bloomberg.com
©2022 Bloomberg L.P.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.